Dr. Bruno Holthof
CEO of Oxford University Hospitals NHS Foundation Trust (OUH).
Join us to our upcoming virtual event on December, 16th at 7PM with Dr. Bruno Holthof (HBS-MBA’88) CEO of Oxford University Hospitals which administered the first human COVID-19 vaccine on April 23.
Bruno will share with us his perspective on accelerating the development and distribution of a new vaccine with potential global impact. We are very grateful to Dr. Holtholf for his particpation in this event.
Dr Bruno Holthof is the Chief Executive Officer (CEO) of Oxford University Hospitals NHS Foundation Trust (OUH). OUH employs 12,000 staff across four hospital sites and 44 other locations.
Before OUH, he was CEO of the Antwerp Hospital Network. During this period, he transformed ZNA into the most profitable hospital group in Belgium. Before becoming a CEO, he was a partner at McKinsey & Company. During this period, he served a wide range of healthcare clients in Europe and the United States and gained significant expertise in the areas of strategy, organisation and operations.
He holds an MBA from the Harvard Business School and an MD/PhD from the University of Leuven.
The event will last 1 hour with Q&A format. We encourage you to send us the questions to our email: email@example.com. In any case, we can also ask questions during the session.
We will continue to have the support of SAP our main sponsor and technology expert. We will use their ON24 platform.
Best regards and stay safe!
HARVARD CLUB OF SPAIN
* Los asistentes se comprometen a guardar confidencialidad sobre los contenidos y opiniones vertidas en los eventos siguiendo la regla de Chatham House
**Las opiniones vertidas en los eventos organizados por la Asociación Harvard Club de España son de exclusiva responsabilidad de sus autores y no necesariamente representan la opinión ni de la Asociación Harvard Club de España ni de la Universidad de Harvard.